Variant report

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr1:179545678-179546012	IMR90	lung:	n/a	chr1:179545848-179545859
2	CEBPB	chr1:179545735-179546007	K562	blood:	n/a	chr1:179545848-179545859
3	CEBPB	chr1:179545692-179546028	HepG2	liver:	n/a	chr1:179545848-179545859

Variant related genes	Relation type
NPHS2	TF binding region

rs_ID	r²[population]
rs1060775	1.00[JPT][hapmap]
rs1079292	0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];1.00[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs10798682	1.00[JPT][hapmap]
rs10798689	0.80[YRI][hapmap]
rs10913776	1.00[JPT][hapmap]
rs10913804	1.00[JPT][hapmap]
rs10913807	1.00[JPT][hapmap]
rs12131398	1.00[JPT][hapmap]
rs12131400	1.00[JPT][hapmap]
rs12136100	1.00[JPT][hapmap]
rs1328596	1.00[JPT][hapmap]
rs1410590	1.00[JPT][hapmap]
rs1831180	1.00[JPT][hapmap]
rs1928004	1.00[JPT][hapmap]
rs1999069	0.83[EUR][1000 genomes]
rs3930537	0.88[YRI][hapmap]
rs4255343	1.00[JPT][hapmap]
rs4360482	1.00[JPT][hapmap]
rs4606280	1.00[JPT][hapmap]
rs4652404	1.00[JPT][hapmap]
rs4652417	0.83[YRI][hapmap];0.88[AFR][1000 genomes];0.92[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs4652421	0.83[EUR][1000 genomes]
rs4652423	0.83[EUR][1000 genomes]
rs6659294	1.00[JPT][hapmap]
rs6662859	1.00[JPT][hapmap]
rs6696896	1.00[JPT][hapmap]
rs6698201	1.00[JPT][hapmap]
rs749960	1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs7512551	1.00[JPT][hapmap]
rs7514278	1.00[JPT][hapmap]
rs7514875	0.83[EUR][1000 genomes]
rs7517766	1.00[JPT][hapmap];0.94[YRI][hapmap]
rs7518557	0.90[YRI][hapmap]
rs7522064	1.00[JPT][hapmap]
rs928016	1.00[JPT][hapmap]
rs963062	1.00[JPT][hapmap]
rs964982	1.00[JPT][hapmap]

Chromatin state (count:16 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:179543200-179546400	Bivalent/Poised TSS	Fetal Kidney	kidney
2	chr1:179545200-179546000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
3	chr1:179545400-179546000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr1:179545600-179546000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
5	chr1:179545600-179546000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
6	chr1:179545600-179546000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr1:179545600-179546000	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr1:179545600-179546000	Bivalent Enhancer	Small Intestine	intestine
9	chr1:179545800-179546000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
10	chr1:179545800-179546000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
11	chr1:179545800-179546000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
12	chr1:179545800-179546000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
13	chr1:179545800-179546000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr1:179545800-179546000	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
15	chr1:179545800-179546000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
16	chr1:179545800-179546200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell

Quick Search: